Preclinical evaluation of anti-VEGFR2 monoclonal antibody ramucirumab labelled with zirconium-89 for tumour imaging.

Novy, Zbynek; Janousek, Jiri; Barta, Pavel; Petrik, Milos; Hajduch, Marian; Trejtnar, Frantisek

Novy, Zbynek; Janousek, Jiri; Barta, Pavel; Petrik, Milos; Hajduch, Marian; Trejtnar, Frantisek.

Afiliação

Novy Z; Palacky University Olomouc, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Olomouc, Czech Republic.
Janousek J; Faculty of Pharmacy in Hradec Kralove, Department of Pharmacognosy, Charles University, Hradec Kralove, Czech Republic.
Barta P; Faculty of Pharmacy in Hradec Kralove, Department of Biophysics and Physical Chemistry, Charles University, Hradec Kralove, Czech Republic.
Petrik M; Palacky University Olomouc, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Olomouc, Czech Republic.
Hajduch M; Palacky University Olomouc, Faculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Olomouc, Czech Republic.
Trejtnar F; Faculty of Pharmacy in Hradec Kralove, Department of Pharmacology and Toxicology, Charles University, Hradec Kralove, Czech Republic.

J Labelled Comp Radiopharm ; 64(7): 262-270, 2021 06 15.

Article em En | MEDLINE | ID: mdl-33818828

Assuntos

Radioisótopos; Zircônio

Palavras-chave

PET; VEGF; VEGFR; angiogenesis; monoclonal antibody; ramucirumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Zircônio Idioma: En Revista: J Labelled Comp Radiopharm Ano de publicação: 2021 Tipo de documento: Article País de afiliação: República Tcheca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google